-
1
المؤلفون: Hongchao Zhen, Yuhan Wei, Yuting Lu, Xiaoyue Jiang, Jiangtao Jin, Miao Wang, Qin Li
المصدر: Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1584-1595 (2021)
Immunity, Inflammation and Diseaseمصطلحات موضوعية: efficacy prediction, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Immunology, Programmed Cell Death 1 Receptor, ECOG Performance Status, Gastroenterology, Metastasis, clinical efficacy, PD‐1/PD‐L1 inhibitor, PD-L1, Internal medicine, Carcinoma, Non-Small-Cell Lung, Immunology and Allergy, Medicine, Humans, In patient, Objective response, Immune Checkpoint Inhibitors, Retrospective Studies, biology, business.industry, Retrospective cohort study, Immunotherapy, Original Articles, RC581-607, medicine.disease, Confidence interval, advanced solid tumor, biology.protein, Original Article, immunotherapy, Immunologic diseases. Allergy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac27fe9d73aa684f34a349e058effc4Test
https://doaj.org/article/7e67fd62bbea405ca3ca1c424f2c1796Test -
2
المؤلفون: Kai Wang, Xiangdong Zhou, Qi Wang, Xiaoxia Cui, Xiaoyu Zhang, Chunxue Bai, Li Zhang, Jian Zhang, Jianping Zhao, Peng Song, Xiaoju Zhang, Faguang Jin, Yao Yu, Li Bai, Xiaoli Zhu, Yanbin Zhou, Chengzhi Zhou
المصدر: Thoracic Cancer
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Adolescent, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, NSCLC, Multi‐omics, B7-H1 Antigen, Young Adult, Study Protocol, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, PD‐1/PD‐L1 inhibitor, Carcinoma, Non-Small-Cell Lung, PD-L1, Internal medicine, Biomarkers, Tumor, medicine, Humans, Molecular Targeted Therapy, predictive biomarker, Lung cancer, Aged, Response rate (survey), biology, business.industry, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Clinical trial, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, Immunohistochemistry, Female, Nivolumab, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb9f8018da18f4739ee639337e1c7efTest
https://doi.org/10.1111/1759-7714.13078Test